Abstract: Methods, systems, and apparatus, including computer programs encoded on a computer storage medium, for normalizing, compressing, and correlating vulnerabilities are disclosed. In one aspect, a method includes the actions of generating a first and second copy of a software target. The actions further include providing the first copy to a first scanning tool and the second copy to a second scanning tool. The actions further include receiving a first scanning tool output that identifies a first issue of the software target. The actions further include receiving a second scanning tool output that identifies a second issue of the software target. The actions further include determining that the first issue and the second issue are a same issue. The actions further include generating a combined issue of the first issue and the second issue. The actions further include outputting a notification that includes the combined issue.

Abstract: Methods, systems, and apparatus, including computer programs encoded on a computer storage medium, for normalizing, compressing, and correlating vulnerabilities are disclosed. In one aspect, a method includes the actions of generating a first and second copy of a software target. The actions further include providing the first copy to a first scanning tool and the second copy to a second scanning tool. The actions further include receiving a first scanning tool output that identifies a first issue of the software target. The actions further include receiving a second scanning tool output that identifies a second issue of the software target. The actions further include determining that the first issue and the second issue are a same issue. The actions further include generating a combined issue of the first issue and the second issue. The actions further include outputting a notification that includes the combined issue.

Abstract: A medical waste container includes a reduced-weight section having a high density outer skin layer, a high density inner skin layer, and a cellular core layer between the outer skin layer and inner skin layer. A method for manufacturing a medical waste container includes the steps of combining a thermoplastic polymer with a endothermic chemical blowing agent, heating the polymer and blowing agent to form a melted mixture, maintaining the mixture under conditions that prevent or substantially prevent activation of the blowing agent, injecting the mixture into a mold having a mold chamber and chamber walls, the mold being at a pressure that is sufficiently low to activate the blowing agent and initiate cell formation in the mold chamber, and cooling the melted mixture in the mold to form skin layers in the mixture where the mixture contacts the chamber walls.

Abstract: Fungicidal pyrimidine derivatives and the use as a fungicide of the compounds of formula (1): wherein R1 is H, C1-C6alkyl, C2-C6alkenyl, C2-C6alkynyl, C3-C6cycloalkyl, C1-C6alkoxy, C3-C6cycloalkoxy, C1-C6alkylthio, C1-C6alkylsulfinyl, C1-C6alkylsulfonyl, phenyl, pyridinyl or azolyl groups, (being optionally substituted by one or more substituents); or N(R4)C(O)R5, R2 is polyfluoroalkyl, R3 is fluorine, chlorine, bromine or iodine; ethenyl or ethynyl (being optionally substituted by one or more of halogen), R4 and R5 are, independently, H, C1-C6alkyl, C2-C6alkenyl or C2-C6alkynyl groups, (being optionally substituted by one or more of halogen or cyano); or R4 and R5 can join together to form a 5 or 6-membered ring, Q is a heteroaromatic ring selected from the following ring system; imidazol-1-yl, pyrazol-1-yl, 1,2,3-triazol-1-yl, 1,2,3-triazol-2-yl, 1,2,4-triazol-1-yl, 1,2,4-triazol-4-yl, benzimidazol-1-yl or tetrazol-5-yl groups, (being optionally substituted by one or more of substituents).

Abstract: Fungicidal pyrimidine derivatives and the use as a fungicide of the compounds of formula (1): wherein R1 is H, C1-C6alkyl, C2-C6alkenyl, C2-C6alkynyl C3-C6cycloalkyl, C1-C6alkoxy, C3-C6cycloalkoxy, C1-C6alylthio, C1-C6alkylsulfinyl, C1-C6alkylsulfonyl, phenyl, pyridinyl or azolyl groups, (being optionally substituted by one or more substituents); or N(R4)C(O)R5, R2 is polyfluoroalkyl, R3 is fluorine, chlorine, bromine or iodine; ethenyl or ethynyl (being optionally substituted by one or more of halogen), R4 and R5 are, independently, H, C1-C6alkyl, C2-C6alkenyl or C2-C6alkynyl groups, (being optionally substituted by one or more of halogen or cyano); or R4 and R5 can join together to form a 5 or 6-membered ring, Q is a heteroaromatic ring selected from the following ring system; imidazol-1-yl, pyrazol-1-yl, 1,2,3-triazol-1-yl, 1,2,3-triazol-2-yl, 1,2,4-triazol-1-yl, 1,2,4-triazol-1-yl, benzimidazol-1-yl or tetrazol-5-yl groups, (being optionally substituted by one or more of substituents).